secwatch.observer — SEC 8-K summary
======================================

Issuer:     Z Squared Inc. (ZSQR)
CIK:        0001759186
Form:       8-K
Filed at:   2026-04-24T23:59:59+00:00
Accession:  0001683168-26-003199
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.85
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Coeptis completes reverse merger with Z Squared; shares to trade as ZSQR April 27
--------------------------------------------------------------------------------

- Coeptis Therapeutics completes business combination with computing infrastructure firm Z Squared Inc.
- Combined entity renamed Z Squared Inc.; shares to trade on Nasdaq Global Market under ZSQR starting April 27, 2026.
- Prior to close, Coeptis distributed its biopharmaceutical business to its stockholders via pro rata distribution.
- Post-merger: ~51.5M shares outstanding; former Z Squared stockholders own ~85%, legacy Coeptis holders own ~15%.
- Z Squared COO cites vertically integrated platform across three states with dynamic power management and hardware lifecycle program.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759186/000168316826003199/0001683168-26-003199-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759186/000168316826003199/coeptis_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-26-003199

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer